Jennifer Klemmer - Department of Internal Medicine V, Heidelberg University Hospital

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 9 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Anti-SARS-CoV-2 Antibody-Containing Plasma Improves Outcome in Patients with Hematologic or Solid Cancer and Severe COVID-19: a Randomized Clinical Trial

Claudia M. Denkinger,Maike Janssen,Ulrike Schäkel,Julia Gall,Albrecht Leo,Patrick Stelmach,Stefan F. Weber,Johannes Krisam,Lukas Baumann,Jacek Stermann,Uta Merle,Markus A. Weigand,Christian Nusshag,Lars Bullinger,Jens-Florian Schrezenmeier,Martin Bornhäuser,Nael Alakel,Oliver Witzke,Timo Wolf,Maria J. G. T. Vehreschild,Stefan Schmiedel,Marylyn M. Addo,Felix Herth,Michael Kreuter,Phil-Robin Tepasse,Bernd Hertenstein,Mathias Hänel,Anke Morgner,Michael Kiehl,Olaf Hopfer,Mohammad-Amen Wattad,Carl C. Schimanski,Cihan Celik,Thorsten Pohle,Matthias Ruhe,Winfried V. Kern,Anita Schmitt,Hanns-Martin Lorenz,Margarida Souto-Carneiro,Mary Gaeddert,Niels Halama,Stefan Meuer,Hans-Georg Kräusslich,Barbara Müller,Paul Schnitzler,Sylvia Parthé,Ralf Bartenschlager,Martina Gronkowski,Jennifer Klemmer,Michael Schmitt,Peter Dreger,Katharina Kriegsmann,Richard F. Schlenk,Carsten Müller-Tidow

Nature Cancer（2022）

引用25浏览0WOSNATURE引用

1142. Plasma with High Titers of Anti-Sars-cov2 Antibodies Improves Outcome of COVID-19 in Patients with Hematological Malignancy and Cancer in a Randomized Controlled Trial

Open forum infectious diseases（2022）

引用0浏览0引用

Anti-SARS-CoV-2 Antibody Containing Plasma Improves Outcome in Patients with Hematologic or Solid Cancer and Severe COVID-19 Via Increased Neutralizing Antibody Activity – a Randomized Clinical Trial

Claudia M. Denkinger,Maike Janssen, Ulrike Schaekel,Julia Gall,Albrecht Leo, Patrick Stelmach, Stefan Weber,Johannes Krisam,Lukas Baumann,Jacek Stermann,Uta Merle,Markus A. Weigand,Christian Nußhag,Lars Bullinger,Jens-Florian Schrezenmeier,Martin Bornhaeuser,Nael Alakel,Oliver Witzke,Timo Wolf,Maria J.G.T. Vehreschild,Stefan Schmiedel,Marylyn M. Addo,Felix Herth,Michael Kreuter,Phil‐Robin Tepasse,Bernd Hertenstein, Mathias Haenel,Anke Morgner,Michael Kiehl,Olaf Hopfer, Mohammad-Amen Wattad,Carl Christoph Schimanski,Cihan Celik,Thorsten Pohle, Matthias Ruhe,Winfried V. Kern,Anita Schmitt,Hanns‐Martin Lorenz,Margarida Souto-Carneiro,Mary Gaeddert,Niels Halama,Stefan Meuer, Hans-Georg Kraeusslich, Barbara Mueller,Paul Schnitzler,Sylvia Parthé,Ralf Bartenschlager,Martina Gronkowski,Jennifer Klemmer,Michael Schmitt,Peter Dreger,Katharina Kriegsmann,Richard F. Schlenk,Carsten Müller-Tidow

medRxiv (Cold Spring Harbor Laboratory) (2022)

引用2浏览0引用

The Mtor Inhibitor Temsirolimus Added to Rituximab Combined with Dexamethasone, Cytarabine, and Cisplatinum (R-DHAP) for the Treatment of Patients with Relapsed or Refractory DLBCL – Results from the Phase-II STORM Trial

Mathias Witzens-Harig,Andreas Viardot,Ulrich Keller,Julia Wosniok,Oliver Deuster,Jennifer Klemmer, Anne-Marie Geueke,Julia Meissner,Anthony D. Ho,Johannes Atta,Reinhard Marks,Paul La Rosee,Christian Buske,Martin H. Dreyling,Georg Hess

HemaSphere（2021）

引用6浏览0WOS引用

Safety and Efficacy of the CD95-ligand Inhibitor Asunercept in Transfusion-Dependent Patients with Low and Intermediate Risk MDS

T. Boch,T. Luft,M. Mossner,J.C. Jann,D. Nowak,C. Schumann,J. Klemmer,S. Brendel,H. Fricke,C. Kunz,W.K. Hofmann,F. Nolte

Leukemia Research（2017）

引用8浏览0WOS引用

Safety And Efficacy Of The Cd95-Ligand Inhibitor Apg101 In Transfusion-Dependent Patients With Low Risk Mds: Interim Results From A Phase I Study

Tobias Boch,Wolf-Karsten Hofmann,Claudia Kunz,Harald Fricke,Thomas Luft,Max Mossner,Johann Christoph Jann,Daniel Nowak,Christine Folz,Jennifer Klemmer,Susanne Brendel,Anthony D. Ho,Florian Nolte

JOURNAL OF CLINICAL ONCOLOGY（2016）

引用0浏览0引用

Safety and Efficacy of the Cd95-Ligand Inhibitor Apg101 in Transfusion-Dependent Patients with Low Risk Mds: Results from A Phase I Study

Tobias Boch,Thomas Luft,Maximilian Mossner,Johann-Christoph Jann,Daniel Nowak,Christine Folz,Jennifer Klemmer,Susanne Brendel,Harald Fricke,Claudia Kunz,Wolf-Karsten Hofmann,Florian Nolte

BLOOD（2016）

引用2浏览0引用

Rituximab Maintenance Improves Survival in Male Patients with Diffuse Large B-Cell Lymphoma. Results of the Hd2002 Prospective Multicentre Randomized Phase Iii Trial

Mathias Witzens-Harig,Axel Benner,Fabienne McClanahan,Jennifer Klemmer,Julia Brandt, Elke Brants,Michael Rieger,Julia Meissner,Manfred Hensel,Kai Neben,Peter Dreger,Eva Lengfelder,Ingo Schmidt-Wolf,Alwin Kraemer,Anthony D. Ho

British journal of haematology（2015）

引用29浏览0WOS引用

First Results of a Phase-II Study with the New CXCR4 Antagonist POL6326 to Mobilize Hematopoietic Stem Cells (HSC) in Multiple Myeloma (MM)

Stefan Schmitt,Niels Weinhold,Klaus Dembowsky,Kai Neben,Mathias Witzens-Harig, Manfred Braun,Jennifer Klemmer,Patrick Wuchter,Christian Ludin,Anthony D. Ho,Hartmut Goldschmidt

Blood（2010）

引用26浏览0引用

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn